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Summary 15 
Dietary isoflavones have been hypothesised to play a role in hepatic veno-occlusive disease 16 
in captive exotic felids, although empirical evidence is lacking. This study aimed to 17 
investigate the effect of long-term (>1 year) dietary genistein and daidzein exposure on the 18 
hepatic biochemistry and histology of domestic cats. Individual cats were assessed for hepatic 19 
enzyme and bile acid production before and after the removal of isoflavones from their diet in 20 
the treatment group (n=4), and at the same times in unexposed control animals (n=7). No 21 
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 significant differences were detectable in hepatic biochemistry between treatment and control 22 
groups, and all serum values were within the normal reference ranges for domestic cats. 23 
Additionally, treatment animals demonstrated slightly greater areas of fibrosis surrounding 24 
hepatic venules than control animals, but this difference was not statistically significant. On 25 
the basis of the results presented, dietary isoflavones, at the current dose and duration of 26 
exposure do not appear to modulate hepatic enzyme production or histological parameters.  27 
Keywords: cats, feline, soya, isoflavone, liver 28 
Introduction 29 
Dietary isoflavones, such as genistein and daidzein, have previously been shown to elicit a 30 
diverse array of physiological effects including endocrinological, morphological and 31 
histological changes in a variety of tissues or organs in species such as rodents, pigs and 32 
humans (Barnes et al 2000; Ford et al 2006; McClain et al 2006). Isoflavones are structurally 33 
similar to oestradiol and can bind to oestrogen receptors and function as natural selective 34 
oestrogen receptor modulators, although a diverse array of non-hormonal effects and tissue- 35 
or species-specific effects have also been observed in both rodents and humans (Hollander 36 
1997; Barnes et al 2000; Pike 2006).  37 
The liver is also a target of oestrogen activity (Diel et al. 2002), and isoflavones have been 38 
shown to exert a variety of effects on hepatic activities. Both genistein and daidzein have 39 
been associated with hypertrophic effects in the liver (Banz et al., 2004; McClain et al., 40 
2006b). However, studies with soy protein isolate (containing isoflavones) have produced 41 
divergent results, with no effect in female rats and reduced liver weights in male rats (Peluso 42 
et al., 2000; Huang et al., 2005; Tachibana et al., 2005). Likewise, mild hepatoxicity was 43 
only demonstrated following exposure to high isoflavone doses (500mg/kg BW) with these 44 
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 changes reversible, suggesting that normal dietary exposure (estimated to be < 10 mg/kg BW 45 
for domestic cats and captive cheetahs; Bell et al., 2006 and 2010) is unlikely to pose a risk to 46 
hepatic health (McClain et al., 2006b). Moreover, other studies have demonstrated a 47 
protective role for isoflavones against various hepatic insults (Lee et al. 1995; Kang et al. 48 
2001; Liu et al. 2002; Kuzu et al. 2007; Wong et al. 2007).  49 
However, dietary isoflavones have been implicated in the onset or progression of veno-50 
occlusive disease (VOD; hepatic fibrosis) in captive cheetahs (Setchell et al., 1987ab; 51 
Gosselin et al., 1988). This disease is responsible for significant levels of mortality in the 52 
global captive cheetah population (Munson et al., 2005), but the cause(s) are not yet clearly 53 
defined. Hepatic architecture is modulated during VOD and histological changes include 54 
hepatic congestion, haemorrhage, hepatocyte and hepatic stellate cell vacuolation, foci of 55 
extra-medullary haematopoiesis (EMH; a marker for hypoxia, infection and/or precocious 56 
immune response) (Törő et al. 2007), and increased neutrophil and macrophage cell numbers. 57 
However, no controlled study has been conducted to determine the ability of isoflavones to 58 
modulate hepatic parameters in any felid species. Therefore, the aim of this study was to 59 
determine the potential of long term consumption of genistein and daidzein to elicit 60 
detectable effects on hepatic histology or biochemical parameters (as an indication of 61 
hepatocyte health and biliary secretion) in a felid species, the domestic cat.  62 
Materials and Methods 63 
Eleven female short-haired domestic cats were utilised in this study. Premature removal of 64 
four cats from the treatment group (for reasons unrelated to this study) resulted in a low and 65 
uneven sample size. Cats were bred and maintained at the Centre for Feline Nutrition 66 
(Massey University, New Zealand). Kittens were mother-reared until six weeks of age, 67 
during which time they had access to the queen’s diet (a commercial diet which met the 68 
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 AAFCO (2004) standards for gestation and lactation). Previous analysis of this diet 69 
demonstrated it contained a very low (16 µg total isoflavone/g DM) isoflavone 70 
concentrations (Bell et al 2006), and exposed the queens to a total daily isoflavone dose of 71 
approximately 0.56 mg – 0.84 mg/kg BW. Intake of the maternal diet by kittens prior to 72 
weaning was thought to be minimal, but accurate assessment of the intake was not possible 73 
due to co-housing with the queen. However, pre-weaning exposure was identical between 74 
control and isoflavone-treated animals and intake predicted to be equivalent. At six weeks of 75 
age, cats were gradually weaned from the queens and separated into treatment and control 76 
groups. Cats were gradually introduced to the trial diets, and the day of sole consumption of 77 
the trial diet was recorded as the start of the trial for each individual cat. Cats were group-78 
housed (maximum nine per pen) in multi-level outdoor pens (approx. 5 m x 2 m x 3 m), 79 
exposed to natural day/night cycles and provided with daily exercise opportunities and 80 
environmental enrichment. Control and treatment groups were housed in adjacent pens. Each 81 
cat was weighed weekly and body weight was recorded and tracked against the colony 82 
average. Cats had consumed the trial diets for an average of 394 (± 25.73) days at the time of 83 
blood collection. 84 
Cats assigned to the treatment group (n = 4 at study completion) had been exposed to the 85 
dietary isoflavones, genistein and daidzein, since weaning. Cats in the control group (n = 7) 86 
consumed the same base diet as the treatment group, without the addition of isoflavones.  87 
The base diet for both control and treatment groups for the duration of the trial was a moist 88 
feline diet which met the requirements for growth in the domestic cat according to AAFCO 89 
(2009) testing. Previous analysis of this diet demonstrated it contained no detectable 90 
isoflavones (Bell et al 2006). The purified (99.9%) form of each isoflavone, genistein 91 
(150μg/g DM) and daidzein (150μg/g DM) (LC Laboratories, MA, USA) was added to the 92 
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 base diet of the treatment group, to provide a calculated dose of 300 µg total isoflavone/g 93 
DM, which is representative of exposure through consumption of certain commercially 94 
prepared feline diets (Bell et al 2006). Due to the small quantities of powder to be added to 95 
large quantities of base diet it was necessary to use a freeze-dried inert carrier. The same 96 
concentration of freeze-dried carrier was added to the control diet without the addition of 97 
isoflavone powders.  98 
Cats were provided water ad libitum during the trial, and offered enough food to provide each 99 
cat with appropriate energy intake for its age (i.e. 200 kcal/kg BW/d at 10 weeks, gradually 100 
reducing to 88 kcal/kg BW/d by 40 weeks; Legrand-Defretin and Munday 1993). Food intake 101 
per group was accurately weighed on a daily basis. Monthly assessments were made of 102 
individual food intake by separation of each cat into individual metabolism cages for 24 h, 103 
during which time food intake and urinary and faecal output were recorded.  104 
Sub-samples of the control and treatment diets were assayed for isoflavone content 105 
intermittently throughout the trial, according to methodology described in Bell et al (2006). 106 
Ethical approval (MUAEC Protocol No. 06/06) for this trial was obtained from the Massey 107 
University Animal Ethics Committee (2006). 108 
The average age at the time of initial blood collection was 428 (± 25.75) days. Cats were 109 
fasted overnight, prior to an initial (2 ml) blood sample being collected by venipuncture of 110 
the jugular vein. The cats were then offered a meal of basal diet, and a second (1 ml) blood 111 
sample withdrawn by venipuncture, 2 h after ingestion of this meal. Blood was transferred 112 
into vacutainers and centrifuged to collect serum. Following collection of initial blood 113 
samples, the diet of the treatment group was replaced with the control diet (devoid of 114 
isoflavones), while the cats in the control group continued to be maintained on the control 115 
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 diet. Forty days following this dietary change, a second pair of blood samples were collected 116 
and analysed, as described above. 117 
Serum from the pre-prandial blood sample was analysed for alkaline phosphate (ALP), 118 
aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyl 119 
transferase (GGT) and bile acids (Gribbles Pathology Ltd., Palmerston North, NZ). Serum 120 
from the post-prandial blood sample was analysed for bile acid concentration only (Gribbles 121 
Pathology Ltd., Palmerston North, NZ). Serum was analysed within 48 h of collection. 122 
A liver biopsy was obtained from cats that had been exposed to dietary isoflavones for 123 
approximately 394 days, when these animals underwent routine gonadectomy. Briefly, 124 
general anaesthesia was induced with Zoletil 100 (tiletamine and zolazepam 500 mg/ml each; 125 
12 mg/kg BW, sub-cutaneously) (Virbac, Auckland, New Zealand) and maintained with 126 
halothane/oxygen delivered via an endotracheal tube. A midline incision was made in order 127 
to perform routine ovario-hysterectomy. Upon completion of this procedure, a distal liver 128 
lobe was located and a wedge biopsy (0.7 – 1 g) taken from its border. One or two catgut 129 
sutures were used to control haemorrhage of the liver parenchyma (Cole et al. 2002), before 130 
routine abdominal closure. All animals received Temgesic (324 µg/ml buprenorphine 131 
hydrochloride, 0.03 mg/kg BW, sub-cutaneously) (Reckitt Benckiser, Auckland, New 132 
Zealand) for pain relief after surgery, and Ketofen (ketobrofen, 1 mg/kg BW per os) for the 133 
next 48 h. Cats were maintained in individual metabolism cages for 14 days following 134 
surgery, after which time sutures were removed and cats were returned to normal housing.  135 
Each liver biopsy was immediately weighed and transferred to 10% neutral-buffered formalin 136 
(NBF), before processing on a Leica® TP1050 Tissue Processor (Global Science and 137 
Technology, Auckland, NZ). The samples were dehydrated through a series of graded 138 
alcohols (70%, 95% and absolute ethanol, BD, Poole, UK) at ambient temperature, cleared in 139 
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 xylene and impregnated with Paraplast® Tissue embedding Medium (Global Science and 140 
Technology, Auckland, NZ) under pressure at 60°C. The samples were then embedded using 141 
a Leica Histo Embedder (Global Science and Technology, Auckland, NZ) and 3 µm sections 142 
were cut using MicroTec® Rotary Microtome (Global Science and Technology, Auckland, 143 
NZ). The sections were floated onto a Thermo® Tissue Bath (Medica Pacifica, Auckland, 144 
NZ) at 43°C and mounted onto Superfrost, pre-cleaned slides. Half of the slides were then 145 
placed in a 60°C oven for 20 min then stained with haematoxylin and eosin (H&E) on a 146 
Leica® Autostainer XL (Global Science and Technology, Auckland, NZ). 147 
The remaining slides were placed in a 60°C oven for 20 min then dewaxed on a Leica® 148 
Autostainer XL (Global Science and Technology, Auckland, NZ) before staining using the 149 
Masson’s Trichrome method. Following hydration in water, slides were left to mordant in 150 
Bouin’s solution (Merck, Palmerston North, NZ), overnight at room temperature. Slides were 151 
then washed in tap water, stained in Celestine Blue (Merck, Palmerston North, NZ) for 10 152 
min, rinsed again before staining in Mayer’s Haematoxylin (Merck, Palmerston North, NZ) 153 
for 10 min. Slides were rinsed again for 4 min and then stained in Beibrich Scarlet-Acid 154 
Fuchsin (Merck, Palmerston North, NZ) for 2 min before further rinsing. Sections were 155 
covered in 5% Phosphotungstic Acid (Merck, Palmerston North, NZ) for 15 min and then 156 
rinsed prior to staining with Light Green Solution (Merck, Palmerston North, NZ). After 157 
further rinsing, sections were blotted dry with filter paper and placed in 1% Glacial Acetic 158 
Acid (BD, Poole, UK). Sections were then blotted dry again before dehydrating in 95% 159 
ethanol, absolute ethanol, and finally clearing in xylene before mounting.  160 
Liver sections were examined by a veterinary histo-pathologist (W. Roe) who provided a 161 
detailed report of the sections from each cat. The histo-pathologist was blinded to the 162 
treatment groups. Parameters reported were haemosiderin accumulation, intra-hepatocyte 163 
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 vacuolation, hepatocyte degeneration, necrosis or regeneration. The presence/absence and 164 
extent of histological parameters were then tabulated and averaged according to treatment 165 
group. 166 
The extent of fibrous tissue development around three hepatic blood venules (see Figure 1) 167 
was measured using ImageJ software (version 1.38. Rasband 2007; Research Services 168 
Branch, National Institute of Mental Health, MD, USA) and expressed as the percentage of 169 
the total area of each blood venule.  170 
 171 
Figure 1. Liver section from a domestic cat in the current study. Central vein surrounded by 172 
subendothelial fibrosis (stained green/blue). Massons Trichrome stain  173 
Changes in the serum concentrations of enzymes over time were calculated for each cat, and 174 
groups were tested for significant differences in any temporal changes. Differences in 175 
biochemical parameters at the first sampling time (prior to removal of isoflavones from the 176 
treatment group’s diet), were also tested between groups. Residual data was tested for 177 
normality using the Anderson-Darling test. Differences between groups were tested for 178 
significance using the Mann-Whitney test as data was found to be not normally distributed. 179 
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 Differences between the incidence of congestion, vacuolation, extra-medullary 180 
haematopoiesis (EMH) and inflammatory cells in treatment and control groups were tested 181 
using Fisher’s exact test. The median is reported instead of the mean (Glantz, 2005). All 182 
statistical analyses were performed with Minitab software (version 15, Minitab Inc., PA, 183 
USA).  184 
Results and Discussion 185 
No significant differences (P > 0.05) were detected in any biochemical parameters (ALP, 186 
AST, ALT, GGT, fasted or fed bile acids) within the first sampling phase, prior to isoflavone 187 
removal from the diet of the treatment cats (Table 1). Overall, changes in hepatic 188 
biochemistry parameters were generally similar between control and treatment cats. 189 
However, the results of a power analysis suggests that subtle differences were undetectable in 190 
the study, and that only large differences would be considered significant with the available 191 
sample size (a minimum difference of 59.6% with a power of 95%, or a minimum difference 192 
of 46.1% at 80% power). 193 
Changes in these parameters, as well as bile acid response to a meal within each cat (before 194 
and after dietary change) did not differ between groups, or within the treatment group (i.e. 195 
during isoflavone exposure compared to following removal of isoflavones from the diet; P > 196 
0.05) (Table 2).  All parameters were within normal reference ranges for domestic cats, at all 197 
time points. 198 
The consistent increase in ALT and GGT production between first and second sampling, 199 
observed in both control and treatment groups (Table 2), may reflect altered metabolism or 200 
hepatic activity as a consequence of removal of the reproductive tract.  201 
 202 
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 Table 1. Median (lower quartile, upper quartile) hepatic biochemistry parameters following a 203 
394 day (± 25.73) period of dietary isoflavone exposure in the treatment group 204 
 ALP 
(U/L) 
AST 
(U/L) 
ALT 
(U/L) 
GGT 
(U/L) 
Pre-
prandial 
bile acids 
(µmol/L) 
Post- 
prandial 
bile acids 
(µmol/L) 
Bile acid 
response 
to a meal 
(U/L) 
Control 
29     
(25, 31) 
23 
(18, 27) 
43    
(36, 52) 
1.0     
(0, 2.0) 
0.5    
(0.3, 0.5) 
1.5 
(1, 2.2) 
0.9 
(0.6, 1.7) 
Treatment 
56     
(33, 82) 
25 
(18, 35) 
45    
(33, 56) 
0.5     
(0, 1.3) 
0.4 
(0.3, 0.6) 
2.3 
(2.0, 2.8) 
1.7 
(1.4, 2.3) 
 
The increases observed in plasma ALT and GGT may have occurred from hepatocellular 205 
injury, hormonal action, or as a consequence of muscle injury (Roth-Johnson 2004; Webster 206 
2005), all of which are possible mechanisms in these cases. Gonadectomy would have been 207 
associated with a reduction in circulating oestrogen, whilst the muscle trauma resulting from 208 
abdominal opening during gonadectomy may have elicited the increased ALT and GGT 209 
production. However, the lack of significance between changes in the control and treatment 210 
groups ALT and GGT levels suggests that the hepatic production of these enzymes was not 211 
modulated in response to dietary isoflavones, either during exposure or following a 40-day 212 
recovery period. 213 
This is in contrast to previous findings in cheetahs, in which removal of dietary isoflavones 214 
elicited a reduction in ALT three months later (Setchell et al. 1987a). However, this earlier 215 
study did not control for the variable nutrient composition of isoflavone-containing and 216 
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 isoflavone-free diets and as such, the alteration in ALT cannot be apportioned solely to 217 
isoflavones. 218 
 219 
Table 2. Median (lower quartile, upper quartile) change in hepatic biochemistry parameters 220 
after a 40 days period following the removal of isoflavones from the treatment group cats (no 221 
dietary change in the control cats). 222 
 223 
However, the current study utilised a shorter recovery period than Setchell et al. (1987a) and 224 
gonadectomy occurred at the time that isoflavone exposure ceased, both of which may 225 
explain the disparate results. Likewise, it is possible that the dose used in this study was 226 
insufficient to elicit any change in these enzymes, since GGT was only slightly elevated in 227 
rats when exposed to much higher genistein doses of 500 mg/kg BW (McClain et al. 2006b). 228 
Additionally, the sensitivity of ALT for detection of hepatic disease is moderate at best 229 
(Jacob et al. 2002), and only mild elevation of ALT or AST levels were noted in a domestic 230 
cat diagnosed with hepatic VOD (Cave et al. 2002).  231 
 ALP  
(U/L) 
AST  
(U/L) 
ALT 
(U/L) 
GGT  
(U/L) 
 
Pre-
prandial 
bile acids 
(µmol/L) 
Post 
Prandial 
Bile Acids  
(µmol/L) 
Bile acid 
response to 
a meal 
(U/L) 
Control 
13 
(10, 19) 
-4.0 
(-12, 0.5) 
38 
(30, 44) 
2.0   
(1.5, 2.5) 
0.5          
(0.2, 1.6) 
-0.1 
(-0.6, 1.2) 
0.0 
(-2.7, 0.7) 
Treatment 
-7.5 
(-18, 2.5) 
6.5 
(-6.3, 16) 
33 
(19, 48) 
4.5   
(2.3, 12) 
0.1 
(-0.1, 0.1) 
0.4 
(0.1, 0.7) 
0.5 
(0.2, 0.8) 
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 Rats exhibited a mild increase in plasma ALP after chronic exposure to 500 mg genistein/kg 232 
BW (McClain et al. 2006b). In the current study, no statistically significant difference in ALP 233 
concentrations were detected, although the treatment group’s median ALP appeared to be 234 
higher than the control group’s prior to removal of the isoflavones from their diet. Likewise, 235 
no significant changes in ALP were detected within individuals, but values suggest a 236 
reduction in ALP in treated animals following the removal of isoflavones from their diet, 237 
whilst control cats exhibited an increase in median ALP levels. Following a four week 238 
recovery period, rats exhibited significant recovery in the modulation of ALP (McClain et al. 239 
2006b), suggesting that isoflavones may have elicited a non-permanent increase in ALP 240 
production in cats in this study. However, this was not statistically determined due to the low 241 
sample size. In the cat, the combination of relatively low hepatic stores and the short half-life 242 
mean that plasma ALP is an insensitive marker of hepatic injury (Hoffmann et al. 1977). 243 
Thus, the absence of a significant change in serum ALP does not exclude modulation of 244 
hepatic injury.  245 
The lack of difference between groups during the exposure phase, and the observed increase 246 
in ALT following cessation of isoflavone exposure indicates that hepatic injury was not 247 
associated with isoflavone consumption. Unchanged AST concentrations provided further 248 
evidence to support a lack of hepatic insult, since elevations of this enzyme, in combination 249 
with increased ALT levels are generally good indicators of hepatic dysfunction in the cat 250 
(Roth-Johnson 2004; Webster 2005). Rats exposed to significantly higher doses of genistein 251 
also failed to exhibit any change in AST concentration (McClain et al. 2006b). 252 
Serum bile acid concentration is used in veterinary medicine to assess hepatic clearance from 253 
portal circulation and functional hepatic mass (Roth-Johnson 2004; Webster 2005). Fasted 254 
bile acid concentrations may offer greater specificity for detecting hepato-biliary disease than 255 
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 ALP, ALT or GGT. However, bile acid levels are poorly correlated with histological 256 
findings, and may be elevated in cases of intestinal disease (Roth-Johnson 2004; Webster 257 
2005). Inter-individual differences in gall bladder emptying, gastric emptying rate, intestinal 258 
transit rate, ileal bile acid resorption and gut microflora are all known to affect entero-hepatic 259 
recirculation of bile acids (Webster 2005). Moreover pre- and post-prandial bile acid 260 
concentrations in a domestic cat known to be suffering from hepatic VOD were within the 261 
normal reference range for this species (Cave et al. 2002). Given the variability of this 262 
parameter and the small sample size in this study, it is unsurprising that no difference in bile 263 
acid production was detectable between the two groups. In light of the other parameters 264 
concurrently evaluated, our findings indicated no gross liver dysfunction or clinically 265 
significant effects following the consumption of dietary isoflavones under the conditions of 266 
this experiment.  267 
Hepatic adaptation of enzyme production following chronic exposure to isoflavones may 268 
have occurred in this study, and between-group differences may have been more apparent 269 
following acute exposure. However, acute exposure was not measured in the current study 270 
since cats were exposed to dietary isoflavones at weaning which rendered it impossible to 271 
evaluate acute pre- and post-isoflavone exposure responses.  272 
There were few histological abnormalities in any of the liver sections. A lack of haemosiderin 273 
accumulation indicated that any observed congestion and periportal haemorrhage was a 274 
recent occurrence. Intra-hepatocyte vacuolation was not significant, and any inter-individual 275 
variation in vacuolation was thought to represent divergent glycogen accumulation and 276 
reflective of differences in body condition and/or differences in fasting time. 277 
No evidence of hepatocyte degeneration, necrosis or regeneration was observed. One 278 
treatment cat had low numbers of neutrophils around some periportal areas, but these were 279 
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 considered unlikely to be significant. The mean area of fibrous tissue surrounding hepatic 280 
blood venules (Fig. 1b) in control cats represented 28.51% (± 2.60%; range 14.78 – 40.05) of 281 
the venule area, and that of treatment cats was not significantly different (32.84 ± 4.18%; 282 
range 20.72 – 51.16, P > 0.05). A liver section from a domestic cat suffering from hepatic 283 
VOD was also measured from a published photomicrograph (Cave et al., 2002) and found to 284 
exhibit fibrosis covering an area equivalent to 46.75% of the venule lumen area (Figure 2).  285 
 286 
Figure 2. Liver section from a domestic cat with diagnosed hepatic veno-occlusive disease 287 
(VOD) (from Cave et al. 2002). Central vein surrounded by subendothelial fibrosis (stained 288 
dark green/blue). Masson Trichrome stain.  289 
Over half (57% or 4 of 7) of the control cat sections, but all (100%: 4 of 4) of the treatment 290 
group cat sections demonstrated congestion, however this difference was not significant (P > 291 
0.05). No significant difference in the incidence of vacuolation of hepatocytes and Ito cells 292 
was found between control cat sections (86%: 6 of 7) or treatment cat sections (50%: 2 of 4) 293 
(P > 0.05). Extra-medullary haematopoiesis was detected in 14% (1 of 7) of control cat 294 
sections and 25% (1 of 4) of treatment cat sections, but no difference was detectable (P > 295 
0.05). Neutrophils and/or macrophages were not observed in any control group sections (0 of 296 
7), but were seen in 50% (2 of 4) of treatment group sections. However, this difference also 297 
40 µm 
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 failed to achieve statistical significance (P > 0.05). A summary of the histological findings is 298 
provided in Table 3. 299 
The lack of histological changes detected here is in agreement with the biochemistry results. 300 
Sinusoidal and haemorrhagic congestion with perivenular fibrosis are typical histological 301 
signs of VOD in both cheetahs (see Figure 3) and the domestic cat (see Figure 2) (Setchell et 302 
al. 1987a; Cave et al. 2002).  303 
Table 3. Summary of mean hepatic parameter scores in the liver biopsies of control (N = 7) 
and treatment cats (N = 4) at the time of ovario-hysterectomy 
 Control Group Treatment Group 
Congestion  57% 100% 
Vacuolation 86% 50% 
Extra-medullary haematopoiesis 14% 25% 
Neutrophils/macrophage infiltration 0% 50% 
Fibrous area 28.9% 32.8% 
N.B. Data is presented as the percentage of cats with positive observation scores for each 304 
parameter. The exception to this is fibrous area which is presented as the mean area of fibrous 305 
tissue surrounding hepatic blood venules as a percentage of the venule area. 306 
 307 
However, no evidence of hepatic congestion, vacuolation, EMH or inflammatory cell 308 
infiltration was detected in the domestic cats following extended exposure to dietary 309 
isoflavones. Although a greater proportion of cats in the treatment group, compared to the 310 
control group, demonstrated hepatic congestion (100% versus 57%, respectively), this failed 311 
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 to achieve statistical significance, and was most likely due to anaesthesia and surgical 312 
procedures, rather than any underlying hepatic disease.  313 
Similarly, no evidence of hepatic fibrosis or pathology was detected in any cat, regardless of 314 
treatment group. The extent of hepatic fibrous tissue formation around blood venules did not 315 
differ between groups, which suggested that these compounds are unlikely to play an 316 
aetiological role in the VOD. However, hepatic fibrosis is a dynamic process, involving 317 
nonspecific mechanisms which respond to inflammation and/or hepatic injury (Center, 2004). 318 
Additionally, changes in liver architecture were primarily due to the deposition of 319 
extracellular matrix which operates to reduce perfusion and stimulate sinusoid capillarisation 320 
and collagenisation (Center 2004). The chronic nature of the appearance of these effects 321 
indicates that differences between treatment and control animals in the current study may not 322 
have become detectable until much later in life.  323 
 324 
Figure 3. Liver section from a cheetah with veno-occlusive disease (Courtesy Wellington 325 
Zoo, New Zealand) - central vein surrounded by subendothelial fibrosis (stained blue using  326 
Massons Trichrome stain)  327 
25 µm 
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 Furthermore, unlike cheetahs in which the disease is relatively common, hepatic VOD has 328 
only been reported in one domestic cat (Cave et al. 2002). It appears likely that the domestic 329 
cat and cheetah differ in their susceptibility to VOD or the biological action of isoflavones, or 330 
other environmental factors may be responsible for the incidence of VOD in captive cheetahs.  331 
Budd-Chiari-like syndrome is a rare condition which has only been reported in two domestic 332 
cats, and is typified by hepatic venous outflow obstruction (Cave et al. 2002), potentially 333 
related to VOD. Elevated levels of tumour necrosis factor-alpha (TNF-α) and Interleukin-1β 334 
are observed in association with this syndrome, although it is unclear as to whether they play 335 
an aetiological or responsive role (Cave et al. 2002). Interestingly, the ability of isoflavones 336 
to inhibit TNF-α (Kang et al. 2005), suggests that dietary isoflavone intake is more likely to 337 
reduce, rather than increase, the risk of hepatic fibrosis and VOD in domestic cats. Such a 338 
protective mechanism has been postulated in other studies (Kang et al. 2001; Liu et al. 2002). 339 
Although the current study was not designed to assess cellular proliferation or hepatic 340 
toxicity, the lack of difference between control and treatment animals indicates that neither 341 
beneficial nor detrimental effects were elicited in the liver following isoflavone exposure, 342 
under the conditions of this trial.  343 
Conclusions 344 
The influence of dietary isoflavones, genistein and daidzein, on hepatic biochemistry and 345 
histology in the domestic cat was investigated here for the first time. The purified aglycones 346 
of genistein and daidzein, at the dose and duration of exposure utilised here, do not appear to 347 
modulate hepatic enzyme production or histological parameters in the domestic cat. 348 
Modulation of biochemical parameters was minor if present at all, and failed to achieve 349 
statistical significance or exceed normal reference ranges for clinically healthy cats. 350 
However, caution is warranted in extrapolating these findings to felids exposed to soy-351 
17 
 
 derived isoflavone glycosides or other phytoestrogen compounds. Although larger sample 352 
sizes are needed to confirm our findings, dietary isoflavones are not considered likely to exert 353 
hepatic changes with any clinical implications. 354 
 355 
Acknowledgements 356 
This study was funded by the Centre for Feline Nutrition, Massey University. Heather Nicol, 357 
Kelly Rutherfurd, Margreet Hekman and Karin Weidgraaf are gratefully acknowledged for 358 
their assistance in animal care and sample collection. 359 
 360 
References 361 
AAFCO. (2009) Official publication of the Association of American Food Control Officials 362 
Inc. Oxford, Indiana, USA.  363 
BARNES, S., KIM, H., DARLEY-USMAR, V., PATEL, R., XU, J., BOERSMA, B., and 364 
LUO, M. (2000) Beyond ERα and ERβ: estrogen receptor binding is only part of the isoflavone 365 
story. Journal of Nutrition, 130: 656S – 657S. 366 
BANZ, W., HAUCK, S., GENAME, B., WINTERS, T., and BARTKE, A. (2004)  Soy 367 
isoflavones modify liver free radical scavenger systems and liver parameters in Sprague-368 
Dawley rats. Journal of Medicinal Food, 7 (4): 477 – 481. 369 
BELL, K.M., S.M. RUTHERFURD, and HENDRIKS, W.H. (2006) The isoflavone content 370 
of commercially available feline diets in New Zealand. New Zealand Veterinary Journal, 54: 371 
103–108. 372 
18 
 
 CAVE, T.A., MARTINEAU, H., DICKIE, A., THOMPSON, H., and ARGYLE, D.J. 373 
(2002) Idiopathic hepatic veno-occlusive disease causing Budd-Chiari-like syndrome in a cat. 374 
Journal of Small Animal Practice, 43: 41-415. 375 
CENTER, S.H. (2004) Metabolic, antioxidant, nutraceutical, probiotic and herbal therapies 376 
relating to the management of hepatobiliary disorders. Veterinary Clinics: Small Animal 377 
Practice, 34: 67 – 172. 378 
COLE, T.L., CENTER, S.A., FLOOD, S.N., ROWLAND, P.H., VALENTINE, B.A., 379 
WARNER, K.L., and ERB, H.N. (2002) Diagnostic comparison of needle and wedge biopsy 380 
specimens of the liver in dogs and cats. Journal of the American Veterinary Medical 381 
Association, 220: 1483 – 1490. 382 
DIEL, P., HERTRAMPF, T., SEIBEL, J., LAUDENBACH-LESCHOWSKY, U.,  383 
KOLBA, S., and VOLLMER, G. (2006) Combinatorial effects of the phytoestrogen genistein 384 
and of estradiol in uterus and liver of female Wistar rats. Journal of Steroid Biochemistry and 385 
Molecular Biology, 102: 60–70. 386 
FORD, J.A. JR., CLARK, S.G., WALTERS, E.M., WHEELER, M.B., and HURLEY, 387 
W.L. (2006) Estrogenic effects of genistein on reproductive tissues of ovariectomized gilts. 388 
Journal of Animal Science, 84: 834 – 842. 389 
GLANTZ, S.A. (2005) How to summarise data, in MALLEY, J., LEBOWITZ, H., DAVIS, 390 
K. (Eds.) Primer of Biostatistics, sixth edition, pp. 11-39 (The McGraw-Hill Companies Inc, 391 
USA). 392 
GOSSELIN, S.J., LOUDY, D.L., TARR, M.J., BALISTRERI, W.F., SETCHELL, 393 
K.D.R., JOHNSTON, J.O., KRAMER, L.W., and DRESSER, B.L. (1988) Veno-394 
occlusive disease of the liver in captive cheetah. Veterinary Pathology, 25: 48 – 57. 395 
19 
 
 HOFFMANN, W.E., RENEGAR, W.E., and DORNER, J.L. (1977). Serum half-life of 396 
intravenously injected intestinal and hepatic alkaline phosphatase isoenzyme in the cat. 397 
American Journal of Veterinary Research, 38(10): 1637 – 1639.  398 
HOLLANDER, D. (1997) Environmental effects on reproductive health: the endocrine 399 
disruption hypothesis. Family Planning Perspectives, 29(2): 82 – 92.  400 
HUANG, W., WOOD, C., L’ABBE, M.R., GILANI, G.S., COCKELL, K.A., and XIAO, 401 
C.W. (2005). Soy protein isolate increases hepatic thyroid hormone receptor content and 402 
inhibits its binding to target genes in rats. Journal of Nutrition, 135: 1631 – 1635. 403 
JACOB, I., SPILLMAN, T., BURKHARDT, E., SCHEIDER, M., and GRUNBAUM, E. 404 
(2002) Sensitivity of different liver parameters for the diagnosis of hepatopathies in the cat. 405 
Tierarztliche Praxis Ausgabe Kleintiere Heimtiere, 30 (4): 305 – 310. 406 
KANG, L.P., QU, L.H., ZHANG, J.P., SHI, N,, ZHANG, M., WU, T.M., and CHEN, J. 407 
(2001) Effect of genistein and quercetin on proliferation, collagen synthesis, and type I 408 
procollagen mRNA levels of rat hepatic stellate cells. Acta Pharmacologica Sinica, 22 (9): 409 
793 – 796. 410 
KANG, J.S., YOON, Y.D., HAN, M.H., HAN, S-B., LEE, K., KANG, M.R., MOON, E-411 
Y., JEON, Y.J., PARK, S-K., and KIM, H.M. (2005) Estrogen receptor-independent 412 
inhibition of tumor necrosis factor-α gene expression by phytoestrogen equol is mediated by 413 
blocking nuclear factor-ĸB activation in mouse macrophages. Biochemical Pharmacology, 414 
71: 136 – 143. 415 
KUZU, D., METIN, K., DAGLI, A.F., AKDEMIR, F., ORHAN, C., YALNIZ, M., 416 
OZERCAN, I.H., SAHIN, K., and BAHCECIOGLU, I.H. (2007) Protective role of 417 
genistein in acute liver damage induced by carbon tetrachloride. Mediators of Inflammation, 418 
Article ID: 36381, 6 pages. 419 
20 
 
 LEE, K.W., WANG, J.H., MURPHY, P.A., and HENDRICH, S. (1995) Soybean 420 
isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by 421 
Phenobarbital in female rat liver. Nutrition and Cancer – An International Journal, 24 (3): 422 
267 – 278. 423 
LEGRAND-DEFRETIN, V., and MUNDAY, H.S. (1993) Feeding dogs and cats for life, in 424 
BURGER, I. (Ed.) The Waltham Book of Companion Animal Nutrition, pp. 57068 (Pergamon 425 
Press, Oxford, UK). 426 
LIU, X-J., YANG, L., MAO, Y-Q., WANG, Q., HUANG, M-H., WANG, Y-P., and WU, 427 
H-B. (2002) Effects of the tyrosine protein kinase inhibitor genistein on the proliferation, 428 
activation of cultured rat hepatic stellate cells. World Journal of Gastroenterology, 8 (4): 739 429 
– 745. 430 
MCCLAIN, R.M., WOLZ, E., DAVIDOVICH, A., and BAUSCH, J. (2006a) Genetic 431 
toxicity studies with genistein. Food and Chemical Toxicology, 44: 42 – 55. 432 
MCCLAIN, R.M., WOLZ, E., DAVIDOVICH, A., PFANNKUCH, F., EDWARDS, J.A., 433 
and BAUSCH, J. (2006b) Acute, subchronic and chronic safety studies with genistein in rats. 434 
Food and Chemical Toxicology, 44: 56 – 80. 435 
MUNSON, L., TERIO, K.A., WORLEY, M., JAGO, M., BAGOT-SMITH, A., and 436 
MARKER, L. (2005) Extrinsic factors significantly affect patterns of disease in free-ranging 437 
and captive cheetah (Acinonyx jubatus) populations. Journal of Wildlife Diseases, 41(3): 542 438 
– 548. 439 
PELUSO, M.R., WINTERS, T.A., SHANAHAN, M.F., and BANZ, W.J. (2000) A 440 
cooperative interaction between soy protein and its isoflavone-enriched fraction lowers 441 
hepatic lipids in male obese Zucker rats and reduces blood platelet sensitivity in male 442 
Sprague Dawley rats. Journal of Nutrition, 130: 2333 – 2342.  443 
21 
 
 PIKE, A.C.W. (2006) Lessons learnt from structural studies of the oestrogen receptor. Best 444 
Practice and Research Clinical Endocrinology and Metabolism, 20(1): 1 – 14. 445 
RASBAND, W.S. (2007) ImageJ. US National Insitute of Health, Bethesda, Maryland, USA. 446 
http://rsb.info.nih.gov/ij/  447 
ROTH-JOHNSON, L. (2004) In vitro assessment of hepatic disease. Waltham Focus, 14(2): 448 
7 – 11. 449 
SETCHELL, K.D.R, GOSSELIN, S.J., WELSH, M.B., JOHNSTON, J.O, BALISTRERI, 450 
W.F., KRAMER, L.W., DRESSER, B.L., and TARR, M.J. (1987a) Dietary estrogens – a 451 
probable cause of infertility and liver disease in captive cheetahs. Gastroenterology, 93: 225–452 
233. 453 
SETCHELL, K.D.R., GOSSELIN, S.J., WELSH, M.B., JOHNSTON, J.O., 454 
BALISTRERI, W.F., and DRESSER, B.L. (1987b) Dietary factors in the development of 455 
liver disease and infertility in the captive cheetah. Proceedings of an International Symposium: 456 
Nutrition, Malnutrition and Dietetics in the Dog and Cat, Hanover, pp. 97-100. 457 
TACHIBANA, N., MATSUMOTO, I., FUKUI, K., ARAI, S., KATO, H., ABE, K., and 458 
TAKAMATSU, K. (2005) Intake of soy protein isolate alters hepatic gene expression in rats. 459 
Journal of Agricultural and Food Chemistry, 53: 4253 – 4257. 460 
TÖRŐ, K., HUBAY, M., and KELLER, E. (2007) Extramedullary haemoatopoiesis in 461 
liver of sudden infant death cases. Forensic Science International, 170: 15 – 19. 462 
WEBSTER, C.R.L. (2005) History, clinical signs and physical findings in hepatobiliary 463 
disease, in ETTINGER, S.J., FELDMAN, E.C. (Eds.) Textbook of Veterinary Internal 464 
Medicine, vol 2, pp. 1422-1434 (Elsevier Sciences, Philadelphia USA). 465 
WONG, M.C.Y., PORTMANN, B., SHERWOOD, R., NIEMELA, O., KOIVISTO, H., 466 
PARKKILA, S., TRICK, K., L’ABBE, M.R., WILSON, J., DASH, P.R., 467 
SRIRAJASKANTHAN, R., PREEDY, V.R., and WISEMAN, H. (2007) The 468 
22 
 
 cytoprotective effect of a-tocopherol and daidzein against d-galactosamine-induced oxidative 469 
damage in the rat liver. Metabolism Clinical and Experimental, 56: 865 – 875.  470 
23 
 
